Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature reviews. Immunology, 13(12):862-74.

 PubMed


Sepsis-induced disseminated intravascular coagulation, symmetrical peripheral gangrene, and amputations.

Hotchkiss RS, Levy JH, Levi M (2013) Sepsis-induced disseminated intravascular coagulation, symmetrical peripheral gangrene, and amputations. Critical care medicine, 41(10):e290-1.

 PubMed


TLR3 agonist improves survival to secondary pneumonia in a double injury model.

Davis CG, Chang K, Osborne D, Walton AH, Ghosh S, Dunne WM, Hotchkiss RS, Muenzer JT (2013) TLR3 agonist improves survival to secondary pneumonia in a double injury model. The Journal of surgical research, 182(2):270-6.

 PubMed


Mechanisms of cardiac and renal dysfunction in patients dying of sepsis.

Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, Bhayani SB, Drewry A, Swanson PE, Hotchkiss RS (2013) Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. American journal of respiratory and critical care medicine, 187(5):509-17.

 PubMed


Inhibition of intestinal epithelial apoptosis improves survival in a murine model of radiation combined injury.

Jung E, Perrone EE, Brahmamdan P, McDonough JS, Leathersich AM, Dominguez JA, Clark AT, Fox AC, Dunne WM, Hotchkiss RS (2013) Inhibition of intestinal epithelial apoptosis improves survival in a murine model of radiation combined injury. PloS one, 8(10):e77203.

 PubMed